ADAPT-DES at 2 Years Offers Insights Into Provider Strategies and Aspirin Monotherapy Beyond 1 Year | tctmd.com
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study - The Lancet
Stents and scaffolds
Thrombosis and myocardial infarction: the role of bioresorbable scaffolds
Improved 3-Year Cardiac Survival After IVUS–Guided Long DES Implantation: A Patient-Level Analysis From 2 Randomized Trials | JACC: Cardiovascular Interventions
Randomized comparison of transradial and transfemoral approach for carotid artery stenting | tctmd.com
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study - The Lancet
ADAPT-DES One-Year Results Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents A Large-Scale, Multicenter, Prospective, Observational Study. - ppt download
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES | JACC: Cardiovascular Interventions
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis | Nature Reviews Cardiology
ADAPT-DES Trial: 1 in 8 patients with PCI-DES have increased mortality
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study - The Lancet
Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents | Circulation: Cardiovascular Interventions
ADAPT-DES One-Year Results Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents A Large-Scale, Multicenter, Prospective, Observational Study. - ppt download
Stent Expansion Indexes to Predict Clinical Outcomes: An IVUS Substudy From ADAPT-DES | JACC: Cardiovascular Interventions
ADAPT-DES One-Year Results Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents A Large-Scale, Multicenter, Prospective, Observational Study. - ppt download
ADAPT-DES One-Year Results Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents A Large-Scale, Multicenter, Prospective, Observational Study. - ppt download
ADAPT-DES One-Year Results Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents A Large-Scale, Multicenter, Prospective, Observational Study. - ppt download
PDF) ADAPT-DES study
Stent Expansion Indexes to Predict Clinical Outcomes: An IVUS Substudy From ADAPT-DES - ScienceDirect
Impact of Smoking on Platelet Reactivity and Clinical Outcomes After Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions
Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI | NEJM
The run-in phase of the prospective WSG-ADAPT HR+/HER2– trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer - Ulrike Nitz,
Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents | Circulation: Cardiovascular Interventions
